Home » Topics » Regulatory » Patents

Patents
RSS

More thrombin inhibitors from BioChem Pharma

Aug. 23, 1996

BioChem Pharma claims thrombin inhibitors for coagulopathies

Aug. 23, 1996

Santen reveals neutral endopeptidase inhibitors

Aug. 23, 1996

Adenosine reuptake inhibitors from Kyowa Hakko

Aug. 23, 1996

Thiazolidinone compounds as antianginal agents from Sankyo

Aug. 23, 1996

Roche reveals EGF-R tyrosine kinase inhibitors

Aug. 23, 1996

Phospholipase A2 inhibitors from SmithKline Beecham

Aug. 23, 1996

More endothelin converting enzyme inhibitors from Warner-Lambert

Aug. 23, 1996

Ciba-Geigy claims endothelin converting enzyme inhibitors

Aug. 23, 1996

Roche discloses ETA antagonists for circulatory disorders

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...